Literature DB >> 23318178

Sulfuretin-induced miR-30C selectively downregulates cyclin D1 and D2 and triggers cell death in human cancer cell lines.

Suman Poudel1, Jinsoo Song, Eun-Jung Jin, Kyung Song.   

Abstract

Sulfuretin (3',4',6'-trihydroxyaurone), one of the key flavonoids isolated from Rhus verniciflua, is known to suppress inflammation and oxidative stress. However, the anti-cancer properties of sulfuretin as well as its mechanism of action remain poorly understood. Here, we show that the expression of miR-30C is markedly enhanced in sulfuretin-stimulated cells, consequently promoting apoptosis and cell cycle arrest in human cancer cell lines. The transient transfection of pre-miR-30C resulted in greater than 70% growth inhibition in PC-3 cells and provided strong evidence that miR-30C selectively suppresses the expression of cyclin D1 and D2, but not cyclin D3. Target validation analysis revealed that 3'-UTR of cyclin D2 is a direct target of miR-30C, whereas suppression by miR-30C of cyclin D1 may occur through indirect mRNA regulation. In addition, silencing miR-30C expression partially reversed sulfuretin-induced cell death. Taken together, our data suggest that miR-30C, a tumor suppressor miRNA, contributes to anti-cancer properties of sulfuretin by negatively regulating cyclin D1 and D2, providing important implications of sulfuretin and miR-30C for the therapeutic intervention of human cancers.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318178     DOI: 10.1016/j.bbrc.2013.01.012

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  miR-106a* inhibits the proliferation of renal carcinoma cells by targeting IRS-2.

Authors:  Yadong Ma; Hongyi Zhang; Xiaolong He; Hongxiong Song; Yayong Qiang; Yi Li; Jixue Gao; Ziming Wang
Journal:  Tumour Biol       Date:  2015-05-28

2.  miR-638 suppresses cell proliferation in gastric cancer by targeting Sp2.

Authors:  Ling Yu Zhao; Yu Yao; Jia Han; Juan Yang; Xiao Fei Wang; Dong Dong Tong; Tu Sheng Song; Chen Huang; Yuan Shao
Journal:  Dig Dis Sci       Date:  2014-03-13       Impact factor: 3.199

3.  MiR-144 inhibits cell proliferation of renal cell carcinoma by targeting MTOR.

Authors:  Cheng Xiang; Shi-Peng Cui; You Ke
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-04-13

Review 4.  Integrating traditional medicine into modern inflammatory diseases care: multitargeting by Rhus verniciflua Stokes.

Authors:  Ji Hye Kim; Yong Cheol Shin; Seong-Gyu Ko
Journal:  Mediators Inflamm       Date:  2014-06-12       Impact factor: 4.711

5.  Delta-tocotrienol suppresses radiation-induced microRNA-30 and protects mice and human CD34+ cells from radiation injury.

Authors:  Xiang Hong Li; Cam T Ha; Dadin Fu; Michael R Landauer; Sanchita P Ghosh; Mang Xiao
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

6.  Ehrlichia chaffeensis TRP47 enters the nucleus via a MYND-binding domain-dependent mechanism and predominantly binds enhancers of host genes associated with signal transduction, cytoskeletal organization, and immune response.

Authors:  Clayton E Kibler; Sarah L Milligan; Tierra R Farris; Bing Zhu; Shubhajit Mitra; Jere W McBride
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

7.  Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells.

Authors:  Y Fang; H Shen; Y Cao; H Li; R Qin; Q Chen; L Long; X L Zhu; C J Xie; W L Xu
Journal:  Braz J Med Biol Res       Date:  2014-01-10       Impact factor: 2.590

8.  BAP18 is involved in upregulation of CCND1/2 transcription to promote cell growth in oral squamous cell carcinoma.

Authors:  Xue Wang; Chunyu Wang; Guangqi Yan; Yuanyuan Kang; Ge Sun; Shengli Wang; Renlong Zou; Hongmiao Sun; Kai Zeng; Huijuan Song; Wei Liu; Ning Sun; Wensu Liu; Yue Zhao
Journal:  EBioMedicine       Date:  2020-02-27       Impact factor: 8.143

Review 9.  Breast Cancer Subtype-Specific miRNAs: Networks, Impacts, and the Potential for Intervention.

Authors:  Raj Pranap Arun; Hannah F Cahill; Paola Marcato
Journal:  Biomedicines       Date:  2022-03-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.